Properties of Cardiac Myosin with Cardiomyopathic Mutations in Essential Light Chains

Daria S Yampolskaya1, Galina V Kopylova2, Daniil V Shchepkin2

  • 1Bach Institute of Biochemistry, Biotechnology Research Center, Russian Academy of Sciences, Moscow, 119071, Russia.

Biochemistry. Biokhimiia
|December 12, 2022
PubMed

Insights

Cardiomyopathy mutations in the MYL3 gene affect cardiac myosin function differently. While some mutations alter actin-myosin interactions, impacting muscle contraction, their precise mechanisms vary.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiovascular Research

Background:

  • Hypertrophic cardiomyopathy is linked to mutations in cardiac myosin genes.
  • The essential light chain of ventricular myosin (ELCv) plays a crucial role in cardiac muscle function.
  • Understanding the impact of specific mutations on myosin function is key to elucidating disease mechanisms.

Purpose of the Study:

  • To investigate the functional consequences of cardiomyopathic mutations (E56G, M149V, E177G) in the MYL3 gene on human ventricular myosin (ELCv).
  • To determine how these mutations affect the actin-myosin interaction at the level of myosin subfragment 1 (S1) and in an in vitro motility assay.

Main Methods:

  • Investigated the actin-activated ATPase activity of isolated myosin subfragment 1 (S1).
  • Utilized an in vitro motility assay to assess the Ca2+-sensitivity and sliding velocity of thin filaments on immobilized myosin.
  • Examined the effects on regulated thin filaments and F-actin filaments.

Main Results:

  • The M149V mutation uniquely increased the actin-activated ATPase activity of S1.
  • All studied mutations significantly enhanced the Ca2+-sensitivity of sliding velocity.
  • Mutations E56G and M149V markedly reduced sliding velocity, while E177G did not.

Conclusions:

  • Despite all mutations being associated with hypertrophic cardiomyopathy, they exert distinct effects on actin-myosin interactions.
  • The findings highlight diverse molecular mechanisms underlying ELCv-related cardiomyopathies.
  • This study provides insights into the structure-function relationships of cardiac myosin.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
31
Overview of Myosin Structure and Function01:15

Overview of Myosin Structure and Function

Myosins are a family of molecular motor proteins, first identified in the skeletal muscles, where they are responsible for muscle contraction. Along with their role in muscle contraction, these proteins also play a role in the intracellular transport of molecules and vesicles. There are twenty-four classes of myosins based on their domain sequence and organization. Of the twenty-four, six classes (Myosin I, Myosin II, Myosin V, Myosin VI, Myosin VII, and Myosin X)  have been well...
4.6K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
36
Specialized Characteristics of Cardiac Muscles01:27

Specialized Characteristics of Cardiac Muscles

The primary role of cardiac muscles is to propel blood throughout the cardiovascular system. The cardiac muscle cells, or cardiomyocytes, exhibit specialized characteristics that allow them to perform this function.
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy...
2.7K
Structure of Cardiac Muscles01:13

Structure of Cardiac Muscles

Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
13.8K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19